Rxlife Trademark Details

Rxlife was registered on Tuesday, September 16, 1997 and is currently owned by Transamerica Mailings, Inc. under the registration number 2098273 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 19 years ago on Saturday, June 19, 2004, according to the United State Patent & Trademark Office

Word Mark	Rxlife
Status	Dead Registered 710 — Cancelled - Section 8

Current Owner

Transamerica Mailings, Inc. of Cleveland, OH

View all trademarks for Transamerica Mailings, Inc.

Other Trademarks for Transamerica Mailings, Inc.

Serial Number	75064686
Registration Number	2098273
Status Date	Saturday, June 19, 2004
Filing Date	Saturday, June 19, 2004
Registration Date	Tuesday, September 16, 1997
Attorney	Joseph J. Corso

Correspondent

Joseph J. Corso
Pearne & Gordon LLP
1801 East 9th Street Suite 1200
Cleveland OH 44114-3108

Case File Statements

Goods & Services	Homeopathic Pharmaceuticals Used to Treat or Stimulate Natural Body Responses to Toxins, Breathing and Respiratory Ailments, Allergies, Cold and Flu Symptoms, Fever, Mild Bronchitis, Headache, Migraine, Earache, Constipation, Indigestion, Sinusitis, Nausea, Intestinal Aliments, Rheumatic Pain, Urinary Tract Discomfort and Ailments, Hemorrhoids, Anal Fissures, Menstrual Discomfort, Hypertension, Nervousness, Fever and Itching of Skin Eruption Diseases, Acne, Candida, Eczema, Menopause Discomfort, Pain and Discomfort Associated with Varicose Veins, Skin Disorders, Pain and Discomfort in the Bladder, Urethra and Kidneys, Temporary Prostrate Swelling and Discomfort, Pain and Urination Difficulties, Nervousness, Insomnia, Nervous Tension, Stress, Anxiety, Exhaustion, Throat Irritation, Teething, Colic, Appetite Control, Discomfort and Itching from Contact with Poison Ivy, Poison Oak or Other Irritant Plants, Dry Skin, Bowel Discomfort, Tobacco Addiction, Diarrhea, Abnormal Sexual Sensitivity, Trauma Pain and Shock

Homeopathic Pharmaceuticals Used to Treat or Stimulate Natural Body Responses to Toxins, Breathing and Respiratory Ailments, Allergies, Cold and Flu Symptoms, Fever, Mild Bronchitis, Headache, Migraine, Earache, Constipation, Indigestion, Sinusitis, Nausea, Intestinal Aliments, Rheumatic Pain, Urinary Tract Discomfort and Ailments, Hemorrhoids, Anal Fissures, Menstrual Discomfort, Hypertension, Nervousness, Fever and Itching of Skin Eruption Diseases, Acne, Candida, Eczema, Menopause Discomfort, Pain and Discomfort Associated with Varicose Veins, Skin Disorders, Pain and Discomfort in the Bladder, Urethra and Kidneys, Temporary Prostrate Swelling and Discomfort, Pain and Urination Difficulties, Nervousness, Insomnia, Nervous Tension, Stress, Anxiety, Exhaustion, Throat Irritation, Teething, Colic, Appetite Control, Discomfort and Itching from Contact with Poison Ivy, Poison Oak or Other Irritant Plants, Dry Skin, Bowel Discomfort, Tobacco Addiction, Diarrhea, Abnormal Sexual Sensitivity, Trauma Pain and Shock

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	006, 018, 044, 046, 051, 052
Status	2 — Sec. 8 – Entire Registration
Status Date	Saturday, June 19, 2004
First Use Anywhere	Tuesday, April 9, 1996
First Use In Commerce	Tuesday, April 9, 1996
Primary Code	005

Trademark Timeline

Feb 28 1996

Trademark application filed with USPTO
Apr 09 1996

First use anywhere for the mark
Apr 09 1996

First use in commerce for the mark
Aug 02 1996

Assigned To Examiner
Aug 16 1996

Non-Final Action Mailed
Oct 17 1996

Examiner's Amendment Mailed
Oct 18 1996

Approved For Pub - Principal Register
Dec 13 1996

Notice of Publication
Jan 14 1997

Published For Opposition
Apr 08 1997

Noa Mailed - Sou Required From Applicant
Jun 18 1997

Use Amendment Filed
Jul 10 1997

Statement of Use Processing Complete
Jul 21 1997

Assigned To Examiner
Jul 22 1997

Allowed Principal Register - Sou Accepted
Sep 16 1997

Registered-Principal Register
Sep 16 1997

Trademark officially registered with the USPTO
Jan 29 2004

Teas Change of Correspondence Received
Jun 19 2004

Cancelled Sec. 8 (6-Yr)